Search

Your search keyword '"Cho, Kathleen R."' showing total 523 results

Search Constraints

Start Over You searched for: Author "Cho, Kathleen R." Remove constraint Author: "Cho, Kathleen R."
523 results on '"Cho, Kathleen R."'

Search Results

102. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

104. Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data

106. Genetic alterations in the adenoma-carcinoma sequence

107. Funding anatomic pathology research: a retrospective analysis of an intramural funding mechanism

109. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

112. Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

113. Ovarian cancer update: lessons from morphology, molecules, and mice

114. ARID1A-mutated ovarian cancers depend on HDAC6 activity

117. BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis

119. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

120. Author response: BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis

125. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy

126. Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium

127. Uterine Sarcoma, Version 1.2016

128. IS "OVARIAN" CANCER A MISNOMER? EXPLORING OVARIAN CANCER ORIGINS IN THE MOUSE.

129. Trp53null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis

134. Cervical Cancer, Version 2.2015

137. Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.

138. Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data

139. Uterine Neoplasms, Version 1.2014

140. Development of Mouse Models of Ovarian Cancer for Studying Tumor Biology and Testing Novel Molecularly Targeted Therapeutic Strategies

141. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.

142. Loss of estrogen receptor 1 enhances cervical cancer invasion.

143. IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.

144. IRS1 regulation by wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype

146. Two Distinct Categories of Focal Deletions in Cancer Genomes

147. Cervical Cancer

149. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

150. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.

Catalog

Books, media, physical & digital resources